Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadahiro Kitamura

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 19, 2024
Useful Biomarkers and Clinical Characteristics of Postpancreatitis Diabetes Mellitus (PPDM)Tadahiro Kitamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 2, 2013
[Obesity and the central regulation of energy metabolism]Tadahiro Kitamura
Journal of Diabetes Investigation|September 26, 2024
Commentary on "Intra-islet α-cell Gs signaling promotes glucagon release"Tadahiro Kitamura
Nature Reviews. Endocrinology|August 21, 2013
The role of FOXO1 in β-cell failure and type 2 diabetes mellitusTadahiro Kitamura
Endocrinology and Metabolism (Seoul, Korea)|February 28, 2024
Glucagon: Physiological and Pharmacological Functions and Pathophysiological Significance in Type 2 DiabetesTadahiro Kitamura
Seikagaku. the Journal of Japanese Biochemical Society|September 20, 2007
[Role of FoxO proteins in insulin signaling]Tadahiro Kitamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 28, 2015
[Significance of glucagon control in the diabetes treatment]Tadahiro Kitamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[The roles of PPAR, C/EBP and FoxO families in adipocyte differentiation and proliferation]Tadahiro Kitamura, Yukari Kitamura
Endocrine Journal|November 5, 2010
Roles of FoxO1 and Sirt1 in the central regulation of food intakeTsutomu Sasaki, Tadahiro Kitamura
Diabetology International|August 5, 2024
Advances in the clinical measurement of glucagon: from diagnosis to therapyTadahiro Kitamura, Masaki Kobayashi
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|March 19, 2024
Useful Biomarkers and Clinical Characteristics of Postpancreatitis Diabetes Mellitus (PPDM)Tadahiro Kitamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 2, 2013
[Obesity and the central regulation of energy metabolism]Tadahiro Kitamura
Journal of Diabetes Investigation|September 26, 2024
Commentary on "Intra-islet α-cell Gs signaling promotes glucagon release"Tadahiro Kitamura
Nature Reviews. Endocrinology|August 21, 2013
The role of FOXO1 in β-cell failure and type 2 diabetes mellitusTadahiro Kitamura
Endocrinology and Metabolism (Seoul, Korea)|February 28, 2024
Glucagon: Physiological and Pharmacological Functions and Pathophysiological Significance in Type 2 DiabetesTadahiro Kitamura
Seikagaku. the Journal of Japanese Biochemical Society|September 20, 2007
[Role of FoxO proteins in insulin signaling]Tadahiro Kitamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 28, 2015
[Significance of glucagon control in the diabetes treatment]Tadahiro Kitamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 20, 2011
[The roles of PPAR, C/EBP and FoxO families in adipocyte differentiation and proliferation]Tadahiro Kitamura, Yukari Kitamura
Endocrine Journal|November 5, 2010
Roles of FoxO1 and Sirt1 in the central regulation of food intakeTsutomu Sasaki, Tadahiro Kitamura
Diabetology International|August 5, 2024
Advances in the clinical measurement of glucagon: from diagnosis to therapyTadahiro Kitamura, Masaki Kobayashi
Pageof 13